Background: Multi-drug resistant tuberculosis has become major public health problem and obstacle to effective control of tuberculosis. Objectives was to study the socio-demographic profile of multi- drug resistant tuberculosis patients and its association with severity of ADR (adverse drug reactions) in DOTS plus centre at tertiary hospital in Himachal Pradesh.Methods: It was a prospective observational study carried out from November 2012 to October 2013 on multi-drug resistant tuberculosis (MDR-TB) patients after approved from Institutional Ethics Committee.Results: Out of 104 patients the mean age of patients was 39.9 ±14.26 years. Majority of the patients were in the economically productive age groups. Multi-drug resistant tuberculosis...
Background: Tuberculosis is the most rambling communicable infectious disease on earth. It is the si...
Background: The emergence of resistance to drugs used to treat tuberculosis (TB) and particularly mu...
The tuberculosis (TB) epidemic is one of the biggest public health challenges in the world today. O...
Background: Between 2006 and 2015, the prevalence of MDR-TB has been found to be as high as 39.9% in...
Background: Drug resistant tuberculosis is a major public health threat that hinders progress in tub...
Background: Drug Resistant Tuberculosis (DR-TB) has frequently been encountered in India, and its pr...
Background; Despite an overall decreasing incidence and mortality rate for tuberculosis (TB), multid...
Background: A high frequency of adverse drug reactions (ADRs) is one of the major challenges in the ...
Background: The emergence of drug resistant mycobacteria has become a significant public health prob...
The World Health Organization (WHO) defines multidrug-resistant tuberculosis (MDR-TB) as resistance ...
Background: There were 4.1% of all new cases and 19% of previously treated patients were diagnosed w...
Background: Multidrug-resistant tuberculosis (MDR-TB) has become a global threat concerning to a ris...
Introduction: Multidrug-resistant tuberculosis (MDR-TB) poses a major threat to control of TB worldw...
Background: Tuberculosis is second leading cause of death in the world. The causative organism is My...
Background: India has largest population of drug resistant tuberculosis, the treatment of which is l...
Background: Tuberculosis is the most rambling communicable infectious disease on earth. It is the si...
Background: The emergence of resistance to drugs used to treat tuberculosis (TB) and particularly mu...
The tuberculosis (TB) epidemic is one of the biggest public health challenges in the world today. O...
Background: Between 2006 and 2015, the prevalence of MDR-TB has been found to be as high as 39.9% in...
Background: Drug resistant tuberculosis is a major public health threat that hinders progress in tub...
Background: Drug Resistant Tuberculosis (DR-TB) has frequently been encountered in India, and its pr...
Background; Despite an overall decreasing incidence and mortality rate for tuberculosis (TB), multid...
Background: A high frequency of adverse drug reactions (ADRs) is one of the major challenges in the ...
Background: The emergence of drug resistant mycobacteria has become a significant public health prob...
The World Health Organization (WHO) defines multidrug-resistant tuberculosis (MDR-TB) as resistance ...
Background: There were 4.1% of all new cases and 19% of previously treated patients were diagnosed w...
Background: Multidrug-resistant tuberculosis (MDR-TB) has become a global threat concerning to a ris...
Introduction: Multidrug-resistant tuberculosis (MDR-TB) poses a major threat to control of TB worldw...
Background: Tuberculosis is second leading cause of death in the world. The causative organism is My...
Background: India has largest population of drug resistant tuberculosis, the treatment of which is l...
Background: Tuberculosis is the most rambling communicable infectious disease on earth. It is the si...
Background: The emergence of resistance to drugs used to treat tuberculosis (TB) and particularly mu...
The tuberculosis (TB) epidemic is one of the biggest public health challenges in the world today. O...